http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102012021728-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89ac64d62baaa791ac712c93832985fd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185
filingDate 2012-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_660fb13934386d0cac9a02ec862069d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13b5de4bb1501dbacca4fb2a52e0d751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db7e1205ecdfc873826de5424d097ae9
publicationDate 2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-102012021728-A2
titleOfInvention Nanoparticle
abstract NANOPARTICLE This invention relates to gelatin nanoparticles comprising lyophilized dry extract of Passiflora alata Curtis, which were developed to be incorporated into pharmaceutical formulations, mainly formulations with anti-ulcer activity.
priorityDate 2012-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8369
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID78168
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID159425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936193
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414059530
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID78168
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID159422
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID159425
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID159422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490720

Total number of triples: 24.